ENTITY
Bloomage Biotechnology

Bloomage Biotechnology (963 HK)

22
Analysis
MaterialsChina
Bloomage Biotechnology Corporation Ltd produces hyaluronic acid used in medical, cosmetic, and food products.
more
bullishGiant Biogene
03 Aug 2022 09:15

Giant Biogene Pre-IPO - The Positives - Fast Growth and Juicy Margins

Giant Biogene aims to raise around US$500m in its Hong Kong IPO. It is a leader in the recombinant collagen market in China.

Logo
451 Views
Share
05 Mar 2021 13:30
Smartkarma Originals

Male Grooming in Asia: Blooming Prospects. Skincare to Drive Growth

Steady expansion in the Male grooming sector in China & India is led by a generational shift in grooming habits and not a passing fad. Only a few...

Logo
1k Views
Share
19 Nov 2020 20:09

Yatsen IPO Trading - A Little More Pricey Now

Yatsen Holding raised around US$617m in its US IPO, by pricing its IPO at the top-end of its range. The company is backed by Hillhouse, Tencent and...

Logo
438 Views
Share
bullishSmartkarma
24 Jun 2017 18:20

Last Week, in Event SPACE (24 June 2017)

In this note, CWT Ltd (CWT SP)’s deal completion probability slides on HNA Group's alleged oversight; PCCW Ltd (8 HK)’s net cash stub looks...

Logo
343 Views
Share
16 Jun 2017 20:32

The Week that Was in Greater China @Smartkarma: TSMC Wins, Chinese Housing, More on May Auto Sales

This is the 5th issue of 'The Week that Was in Greater China@Smartkarma' which features a selection of last week's insights on China, Macau, Hong...

Logo
207 Views
Share
x